Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TAS2940
i
Other names:
TAS2940, TAS-2940, TAS 2940
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Otsuka
Drug class:
pan-HER inhibitor
Related drugs:
‹
dacomitinib (32)
FCN-411 (4)
Z650 (2)
CI-1033 (1)
AC480 (0)
JRF103 (0)
dacomitinib (32)
FCN-411 (4)
Z650 (2)
CI-1033 (1)
AC480 (0)
JRF103 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFRvIII mutation
Solid Tumor
EGFRvIII mutation
Solid Tumor
TAS2940
Sensitive: D – Preclinical
TAS2940
Sensitive
:
D
TAS2940
Sensitive: D – Preclinical
TAS2940
Sensitive
:
D
EGFR exon 20 insertion
Solid Tumor
EGFR exon 20 insertion
Solid Tumor
TAS2940
Sensitive: D – Preclinical
TAS2940
Sensitive
:
D
TAS2940
Sensitive: D – Preclinical
TAS2940
Sensitive
:
D
HER-2 exon 20 insertion
Solid Tumor
HER-2 exon 20 insertion
Solid Tumor
TAS2940
Sensitive: D – Preclinical
TAS2940
Sensitive
:
D
TAS2940
Sensitive: D – Preclinical
TAS2940
Sensitive
:
D
HER-2 amplification
Solid Tumor
HER-2 amplification
Solid Tumor
TAS2940
Sensitive: D – Preclinical
TAS2940
Sensitive
:
D
TAS2940
Sensitive: D – Preclinical
TAS2940
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.